The structural pharmacokinetic design for paclitaxel, accounting for your Cremophor EL™ impact, was a three-compartment model with a nonlinear design for paclitaxel plasma clearance (CL), involving a linear minimize With this parameter in the course of the infusion and also a sigmoidal maximize with time after the infusion.Protection starts with